Spinal Fusion
MiRus receives FDA breakthrough device designation for posterior cervical spine system
MiRus announced it received FDA breakthrough device designation for its Europa posterior cervical system for patients undergoing cervical and upper thoracic spinal fusion, according to a press release.
Novel posterior column osteotomy technique may improve deformity correction in scoliosis
Results showed a novel posterior column osteotomy technique may be effective in improving deformity correction in patients with adolescent idiopathic scoliosis undergoing posterior spinal fusion.
Posterior cervical foraminotomy may be noninferior vs. anterior surgery for radiculopathy
With comparable outcomes at 2 years, posterior cervical foraminotomy may be an effective alternative to anterior cervical discectomy and fusion for patients with cervical radiculopathy, according to published results.
Providence Medical Technology receives FDA clearance for spinal fusion navigation system
Providence Medical Technology Inc. announced FDA clearance of its Corus navigation access system for use with its Corus spinal system and the StealthStation navigation system from Medtronic, according to a press release.
Severe hip OA may increase risk of reoperation after lumbar spinal fusion
Results showed patients with severe hip osteoarthritis who undergo lumbar spinal fusion may be at increased risk for reoperation and preemptive total hip arthroplasty may be warranted for this population.
VIDEO: Use of novel device may avoid spine fusion for adolescent idiopathic scoliosis
In this video, Kevin M. Neal, MD, discussed a novel posterior dynamic distraction device that may be effective for treatment of adolescent idiopathic scoliosis.
Sail Fusion receives FDA clearance of sacroiliac fusion system
Sail Fusion announced FDA clearance of its BowTie sacroiliac fusion system with intraarticular and transfixing components, according to a press release.
Xstim receives FDA premarket application approval of spine fusion stimulator
Xstim Inc. announced it received FDA premarket application approval of its Xstim spine fusion stimulator to promote bone healing after spinal fusion surgery, according to a company press release.
Liposomal bupivacaine may augment pain management for spinal fusion
Results showed patients who received liposomal bupivacaine for pain management during open posterior lumbar decompression and fusion required less opioids during their hospital stay vs. patients who did not receive the anesthetic.
Bioretec receives FDA breakthrough device designation for spinal interbody cage
Bioretec Ltd. received FDA breakthrough device designation for its RemeOs spinal interbody cage for use during intervertebral body fusion in the cervical spine, according to a press release.